Hu rau:Errol Zhou (Mr.)
Tel: ntxiv 86-551-65523315
Mobile/WhatsApp: ntxiv 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Email:sales@homesunshinepharma.com
Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

CAS TSIS TAU: 175131-60-9
Cov mis mos molecular: C15H23ClN2O
Molecular phaus: 282.80900
EINECS TSIS MUAJ: 807-579-6
MDL TSIS YOG: MFCD18433402
Khoom Piav Qhia:
Khoom Lub Npe: (1S-cis) -Milnacipran Hydrochloride CAS TSIS TAU: 175131-60-9
Lub ntsiab lus:
(1S, 2R) -2- (AMinoMethyl) -N, N-diethyl-1-phenylcyclopropanecarboxaMide Hydrochloride;
(1S-cis) -Milnacipran Hydrochloride; LevoMilnacipran hydrochloride;
Milnacipran (1S-cis);
Tshuaj& Lub Cev Muaj Zog:
Tshwm sim: Khoom
Kev Ntsuas: ≥99.00%
Cov Ntaub Ntawv Kev Nyab Xeeb:
Lo Lus Teeb: Ceeb Toom
Cov lus ceeb toom ua ntej: P261-P305+P351+P338
Cov Lus Qhia Teeb Meem: H302-H315-H319-H335
Levomilnacipran (Fetzima®) yog ob hom serotonin -norepinephrine reuptake inhibitor (SNRI) tau pom zoo los ntawm FDA hauv 2013 rau kev kho mob loj kev nyuaj siab (MDD). Levomilnacipran yog lub zog nquag tshaj plaws ntawm kev sib tw Milnacipran, uas tam sim no siv los kho qhov mob cuam tshuam nrog fibromyalgia. Cov tshuaj tau tsim los ntawm Forest Laboratories thiab pab pawg Pierre Fabre.
Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!
Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.
Cim npe nrov: (1s-cis) -milnacipran hydrochloride cas 175131-60-9, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag